|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
Agents identified as
cholesterol inhibitors are useful in preventing and treating cardiovascular
and neurodegenerative diseases associated with over accumulation of
cholesterol in cells. These agents are expected to slow the development of
atherosclerosis and the accumulation of amyloid
beta-peptides in the brain, thereby slowing down the symptoms of
Alzheimer’s disease. Therefore,
methods for detecting and monitoring cellular cholesterol is of critical
importance to human health. Since BCθ
signal can be monitored using fluorescence instead of radioactivity, the use
of BCθ in combination with 25RA and CT43 cells
is well-suited for high-throughput rapid screening for compounds that
interfere with cholesterol accumulation after loading with LDL. These findings are claimed in
the issued United States Patent No. 7,186,519, and the published United
States Patent Application No. 10/534,295.
We are seeking an industrial partner who is interested in their
further refinement and commercialization. (Ref: J215) |
||
|
|
|
|
|
|
|
|
«Technology Transfer Office : Sponsored Projects : Dartmouth College |
|||
|
|
||||
|
11 Rope Ferry Road #6210 |
||||
|
Hanover, NH 03755-1404 |
Phone: (603) 646-3027 |
|||
|
|
|
|
Fax: (603) 646-3670 |
|